14. Drugs for Diabetes and Obesity

Sheila A Doggrell

Discipline of Medical Sciences, Faculty of Science and Technology, Queensland University of Technology, Gardens Point, GPO Box 2434, QLD 4001, Australia

Phone +61 7 38705741 Fax +61 7 31381534 Email sheila.doggrell@qut.edu.au

Reviewer: Petra Czarniak, Curtin University of Technology, Perth

Key words: diabetes, Type 1 diabetes, Type 2 diabetes, physiology of the pancreas, insulin replacement therapy, metformin, acarbose, sulfonylureas, glitazones, glucagon-like peptide-1, exenatide, sitagliptin, obesity, amphetamine, phentermine, orlistat

Contents

14.1 Drugs for diabetes

14.1.1 Diabetes mellitus

14.1.2 Physiology of the pancreas

14.1.3 Insulin replacement therapy

14.1.4 Metformin

14.1.5 Acarbose

14.1.6 Sulfonylureas

14.1.7 Glitazones

14.1.8 Glucagon-like peptide-1, exenatide and sitagliptin

14.2 Drugs for obesity

14.2.1 Introduction

14.2.2 Amphetamine

14.2.3 Phentermine

14.2.5 Orlistat